genvec is developing novel biotechnology-based drugs to treat major unmet medical needs. the company has utilized advances in molecular biology and drug delivery to create product candidates which target the disease and preventative vaccines for treating infectious diseases.

Molecular Cancer Therapeutics Genome Therapeutics Benefits Of Biotechnology Biotechnology Advances Biotechnology Clinical Studies Biotechnology In Medicine Biotechnology Information Biotechnology News Carcinoma Of The Pancreas Cardiovascular Clinical Trials Clinical Trials Studies Clinical Trials Study Congestive Heart Failure Studies Congestive Heart Failure European Clinical Trials Heart Disease Human Biotechnology Impaired Cardiac Function Macular Degeneration Clinical Trials Macular Degeneration Studies

Macular Generation Macular Degeneration Pancreatic Cancer Pancreatic Cancer Cells Pancreatic Cancer Clinical Trials Pancreatic Cancer Cure Pancreatic Cancer Disease Pancreatic Cancer Medication Pancreatic Cancer Studies Pancreatic Cancer Symptoms Pancreatic Cancer Trials Pancreatic Tumors Pancreatice Cancer Information Pancretic Cancer Studies Retinitis Pigmentosa Severe Angina Clinical Trials Severe Coronary Artery Disease Wet Age Macular Degeneration Wet-age Related

Contact:	240-632-0740 x513
Address:	65 W Watkins Mill Rd Gaithersburg, Maryland   20878-4021 , USA
Url:	http://www.genvec.com
Fax:	240-632-0735
Year Established:	1992
Annual Sales:	Below US$1 Million
Business Type:	Service